Magic mushrooms tested for alcoholism in tiny oregon study

NCT ID NCT07189988

Ongoing Disease control Sponsor: Healing Advocacy Fund Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study follows 20 adults in Oregon who are using psilocybin (the active ingredient in magic mushrooms) to help with alcohol use disorder. Researchers are observing how often participants have heavy drinking days before and after psilocybin sessions. The study does not provide treatment itself—it simply watches what happens in a real-world clinic setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: psilocybin
What this could lead to: If successful, this could point toward psilocybin as a helpful tool for reducing heavy drinking in people with alcohol use disorder.
What could go wrong: This is a very small, early observational study with only 20 participants and no control group. Results may not apply to everyone, and psilocybin can cause intense psychological experiences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER

Contacts and locations

Locations

Innertrek Patient Service Center

Portland, Oregon, 97232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.